Tender Title: LPO 27 DRUGS 14 CFA
Reference Number: GEM/2025/B/6189281
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence
The LPO 27 DRUGS 14 CFA tender aims to procure a range of medical supplies essential for military healthcare. The scope of work encompasses the supply of various medicinal products, specifically targeting high-quality pharmaceuticals. The objective is to ensure the health and well-being of military personnel by providing necessary medications in a timely manner.
Scope of Work and Objectives
The scope of this tender includes the delivery of the following drugs:
- Duloxetine 20 mg Tablets
- Syp Mefenamic Acid
- Glycerine Suppositories (Adult size 3g Mould)
- Metoprolol 1 mg per ml
- Dexamethasone Sodium Phosphate (4.4 mg Equivalent to Dexamethasone Phosphate 4 mg per ml)
- Adrenaline Tartrate (ratio 1 to 1000, 1 ml Injection)
- Isosorbide Mononitrate 20 mg Tablets
- Isosorbide Dinitrate 10 mg Tablets
- Lignocaine HCl (2 percent with Adrenaline, ratio 1 to 80000 30 ml Injection)
- Pheniramine Maleate (22.75 mg per ml amp of 2 ml Injection)
- Labetalol HCl 5 mg per ml (4 ml Injection)
- Dobutamine HCl 250 mg (5 ml Injection)
- Dextrose 50 percent (25 ml Injection)
- Magnesium Sulphate 50 percent Injection
The main objective is to enhance the operational readiness of military medical facilities by ensuring an adequate stock of essential medications.
Eligibility Criteria
To be eligible for this tender, bidders must meet specific criteria:
- Be a registered pharmaceutical supplier.
- Possess valid licenses to sell prescription and over-the-counter medications.
- Demonstrate compliance with pharmaceutical quality standards.
Technical Requirements
Bidders are required to adhere to stringent technical specifications outlined for each drug. Compliance with the latest international quality standards, including Good Manufacturing Practices (GMP), is mandatory. All products must have clear labeling, expiration dates, and should meet the prescribed safety and efficacy standards.
Financial Requirements
Bidders should provide a detailed quotation that includes pricing on a per-unit basis for the specified quantities, payment terms, and any applicable taxes. Evidence of financial stability and ability to fulfill orders efficiently may also be required.
Document Submission Details
Interested parties must submit their technical and financial proposals, along with all required documents specified in the tender documentation. Proposals should be submitted through the designated electronic tendering platform.
Special Provisions
This tender may include benefits to Micro, Small, and Medium Enterprises (MSEs) and measures to encourage local startups in alignment with government initiatives to promote local sourcing and manufacturing.
Evaluation Process
The evaluation will be based on established criteria, including but not limited to:
- Compliance with eligibility and technical specifications.
- Competitive pricing.
- Proven experience and reputation in the pharmaceutical sector.
- Delivery timelines and capacity.
Delivery Locations
Successful bidders will be required to deliver medications to designated military healthcare facilities as specified in the tender documentation.
Contact Information
For any inquiries or further clarifications, bidders are advised to refer to the contact information provided in the tender document.
Tender BOQ Items
14 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
5 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, possessing a valid license for pharmaceutical distribution, and compliance with necessary pharmaceutical quality standards. Bidders must demonstrate their ability to provide the required drugs in appropriate quantities and meet all regulatory and operational criteria as outlined in the tender documentation.
Bidders must comply with specific technical specifications such as adherence to Good Manufacturing Practices (GMP) and quality assurance protocols compliant with national and international standards. Each drug’s specifications, including suitable packaging and labeling requirements, must be strictly followed to ensure safety and efficacy.
The Earnest Money Deposit (EMD) is a mandatory submission to demonstrate the bidder’s commitment to the tender process. The specific amount is detailed in the tender documents. Additionally, successful bidders must provide performance security, ensuring contract fulfillment and adherence to stipulated timelines and quality standards.
Bidders should electronically submit their proposals through the specified tendering platform, ensuring the inclusion of all required documents as detailed in the tender announcement. The proposals must be correctly formatted and submitted before the established deadline for consideration in the evaluation process.
MSEs may receive specific benefits such as preferential treatment in the evaluation process, reduced fees or deposits, and opportunities for capacity-building initiatives. Initiatives supporting the ‘Make in India’ policy encourage local production, which fosters sustainable growth and development within the MSE sector as they participate in government tenders.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders